MedTrace Logo

Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis

NCT06939582 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2025-04-29

No results posted yet for this study

Summary

Evaluate the safety, tolerance and efficacy of hydroxychloroquine sulfate tablets the prevention and treatment of oral mucositis and dysgeusia in patients undergoing radiotherapy

Conditions

  • Radiation-induced Oral Mucositis

Interventions

DRUG

Hydroxychloroquine Sulfate Tablets

the trial group use the hydroxychloroquine sulfate tablets (200mg/time, bid)

OTHER

Placebo

the control group use the Placebo

Sponsors & Collaborators

  • Xingchen Peng

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-22
Primary Completion
2025-06-01
Completion
2025-06-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06939582 on ClinicalTrials.gov